Published • loading... • Updated
Loblaw Companies Limited 2026 Q2 - Results - Earnings Call Presentation (TSX:L:CA) 2026-07-30
Shoppers Drug Mart same-store sales rose 4.6% as higher prescription volumes and values helped lift Loblaw’s gross profit and adjusted EBITDA.
- Loblaw Companies Limited reported second-quarter revenue of $15,046 million, a 4.1% increase, with net earnings rising to $751 million or 64 cents per diluted share.
- Shoppers Drug Mart drove growth with 4.6% same-store sales growth, fueled by 7.5% pharmacy and healthcare services expansion led by specialty and chronic prescriptions.
- Food Retail sales reached $10,617 million as store traffic and basket sizes increased; the company opened 14 new locations with half utilizing discount formats.
- On July 1, 2026, the company completed the $1,234 million sale of PC Financial to EQB Inc., receiving $625 million in cash and excess capital release.
- Planned capital expenditures of approximately $2.4 billion for 2026 will strengthen the store network and distribution centers, with management expecting retail earnings to grow faster than sales.
Insights by Ground AI
14 Articles
14 Articles
Loblaw Companies' profit and turnover both increased from one year to the next in the second quarter.
·Montreal, Canada
Read Full Article
The Toronto Star+6 Reposted by 6 other sources
Loblaw Reports Second Quarter Revenue Growth of 4.1% and Adjusted Diluted Net Earnings Per Common Share Growth of 11.9%
BRAMPTON, Ontario, July 30, 2026 (GLOBE NEWSWIRE) -- Loblaw Companies Limited (TSX: L) (“Loblaw” or the “Company”) announced today its unaudited financial results for the second quarter ended June 20,
·Toronto, Canada
Read Full Article
Coverage Details
Total News Sources14
Leaning Left8Leaning Right3Center2Last UpdatedBias Distribution62% Left
Bias Distribution
- 62% of the sources lean Left
62% Left
L 62%
15%
R 23%
Factuality
To view factuality data please Upgrade to Premium
